Sagimet Biosciences Inc.
SGMTPharmaceutical Preparations · SIC 2834 · CIK 0001400118
Revenue FY2025
—
Net Income
$(51.0M)
EPS (Basic)
$-1.58
Net Margin
—
ROE
-45.8%
Total Equity
$111.0M
Shares Out
31M
Sagimet Biosciences Inc. — Pharmaceutical Preparations. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2022–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.
Revenue & Net Income (10Y)
Margin Trends
Investor Ownership · 2 funds in our universe
FundPosition Value% of AUMQoQ ChgWeight
Hillhouse Capital Advisors
Hillhouse Capital Advisors
$5.6M
0.7%
—
Baker Bros. Advisors
Baker Bros. Advisors
$7.4M
0.0%
—
Insider Transactions
Reading stored insider transactions…